NT5E and acute myeloid leukemia: BM stromal cells (BMSCs), specifically, CD73+CD105+CD271+ BMSCs subgroup in AML TME can promote the survival and proliferation of AML cells by secreting growth factors, thereby reducing treatment efficacy (96, 97).